Sanofi Aktie

74,26 EUR -3,69 EUR -4,73 %

14:18:42

STU

68,04 CHF -3,24 CHF -4,55 %

14:24:27

BRX

Sanofi jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.95,80 Mrd. EUR

KGV19,40Div. Rendite4,98%

WKN920657

ISINFR0000120578

SymbolSNYNF

Sanofi Aktien News

Sortieren:Datum Meistgelesen

12.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

09.06.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - May 2025

09.06.25BenzingaBeyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season

09.06.25PR NewswireSanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care

09.06.25GlobeNewswirePress Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

05.06.25GlobeNewswirePress release: Sanofi Launches 2025 Global Employee Stock Purchase Plan

03.06.25GlobeNewswirePress Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector

03.06.25GlobeNewswirePress Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease

02.06.25ZacksSanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines

02.06.25BenzingaSanofi Expands Rare Immunology Portfolio With Blueprint Buyout

02.06.25Business TimesSanofi to buy US biopharma group Blueprint for up to US$9.5 billion

02.06.25Financial TimesSanofi to buy US blood disorder drugmaker for up to $9.5bn

02.06.25PR NewswireSanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

02.06.25GlobeNewswirePress Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

30.05.25BenzingaRegeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

30.05.25GlobeNewswirePress Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

29.05.25GlobeNewswirePress Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs

27.05.25GlobeNewswirePress Release: Sanofi completes acquisition of DR-0201

22.05.25PR NewswireSanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence

22.05.25ZacksSanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

22.05.25BenzingaSanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

22.05.25GlobeNewswirePress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline

21.05.25BenzingaPrice Over Earnings Overview: Sanofi

19.05.25BenzingaNovavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

15.05.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - April 2025

14.05.25BenzingaSanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

14.05.25PR NewswireSanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing

02.05.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - March 2025

30.04.25GlobeNewswirePress Release: Annual General Meeting of April 30, 2025

30.04.25GlobeNewswirePress Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

29.04.25GlobeNewswirePress Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

24.04.25GlobeNewswirePress Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

18.04.25GlobeNewswirePress Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

15.04.25PR NewswireChrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

15.04.25GlobeNewswirePress Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

08.04.25GlobeNewswirePress Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

03.04.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - February 2025

03.04.25GlobeNewswirePress Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

28.03.25GlobeNewswirePress Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.